Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SST's body contour offerings expand with Shippert deal

This article was originally published in Clinica

Executive Summary

Aesthetic surgery specialist Sound Surgical Technologies (SST) has added a range of fat transfer products to its portfolio, after sealing a distribution deal with Centennial, Colorado-based medical devices manufacturer Shippert Medical Technologies. The Tissu-Trans fat transfer line includes cannulas, syringes, tubings and fat reinjection guns. These products will be sold alongside SST's flagship Vaser Lipo system, which is designed to selectively break apart unwanted fat using ultrasonic energy, while sparing the surrounding tissue structures. The addition of Shippert's products, said Louisville, Colorado-based SST, will enable it to become a "one-stop shop" for advanced body sculpting devices and supplies. Financial details of the deal were not disclosed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041813

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel